Guiyang Langmen Biotechnology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Guiyang Langmen Biotechnology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CIVISON. The owner is based in Guiyang City, Guizhou.

Yuntan Street, Guanshanhu District

Room 6 and Room 7, 11th Floor, Unit 1

Guiyang City, Guizhou 550081 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CIVISON
CIVISON
Registered 2024

Trademark Classifications

Guiyang Langmen Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does Guiyang Langmen Biotechnology Co., Ltd. have?

Guiyang Langmen Biotechnology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guiyang Langmen Biotechnology Co., Ltd. file in?

Guiyang Langmen Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 14 (Jewelry). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are Guiyang Langmen Biotechnology Co., Ltd.'s most well-known trademarks?

Guiyang Langmen Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as CIVISON. These are among 1 currently registered trademark in the portfolio.

What is Guiyang Langmen Biotechnology Co., Ltd.'s trademark registration success rate?

Guiyang Langmen Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.